MedTrace Logo

Effects of Lutein Supplementation on Subclinical Atherosclerosis

NCT01534533 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2013-07-22

Study results available
· View outcomes & findings →

Summary

This study is to investigate the possible positive effects of lutein and lycopene supplementation on early atherosclerosis in Beijing.

Conditions

  • Carotid Atherosclerosis
  • Carotid Intimal Medial Thickness 1

Interventions

DIETARY_SUPPLEMENT

Placebo

one gelatine capsule containing starch per day, for 12 months

DIETARY_SUPPLEMENT

Lutein group

one gelatine capsule containing 20mg lutein per day, for 12 months

DIETARY_SUPPLEMENT

Combination group

one gelatine capsule containing 20mg lutein and 20 mg lycopene per day, for 12 months

DIETARY_SUPPLEMENT

Normal lutein control group

subjects without early atherosclerosis, treated with one gelatine capsule containing 20mg lutein per day, for 12 months

Sponsors & Collaborators

  • Peking University

    lead OTHER

Principal Investigators

  • Xiaoming Lin, M.M. · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-06-30
Completion
2012-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01534533 on ClinicalTrials.gov